{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T15:46:40Z","timestamp":1792079200276,"version":"4.4.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.jchf.2024.04.010","type":"journal-article","created":{"date-parts":[[2024,6,3]],"date-time":"2024-06-03T18:44:20Z","timestamp":1717440260000},"page":"990-998","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF"],"prefix":"10.1016","volume":"12","author":[{"given":"Yogesh N.V.","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Noseworthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A.","family":"Borlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy M.","family":"Albert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2024.04.010_bib1","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.jacc.2020.07.009","article-title":"Atrial dysfunction in patients with heart failure with preserved ejection fraction and atrial fibrillation","volume":"76","author":"Reddy","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2024.04.010_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1161\/CIRCULATIONAHA.122.057444","article-title":"Management of atrial fibrillation across the spectrum of heart failure with preserved and reduced ejection fraction","volume":"146","author":"Reddy","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/CIRCULATIONAHA.115.018614","article-title":"Atrial fibrillation begets heart failure and vice versa: temporal associations and differences in preserved versus reduced ejection fraction","volume":"133","author":"Santhanakrishnan","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib4","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.113.001475","article-title":"Temporal relationship and prognostic significance of atrial fibrillation in heart failure patients with preserved ejection fraction: a community-based study","volume":"128","author":"Zakeri","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib5","first-page":"1351","article-title":"Atrial fibrillation burden and atrial shunt therapy in heart failure with preserved ejection fraction","volume":"11","author":"Patel","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"issue":"3","key":"10.1016\/j.jchf.2024.04.010_bib6","first-page":"492","article-title":"Prevalence of subclinical atrial fibrillation in heart failure with preserved ejection fraction","volume":"12","author":"Yang","year":"2024","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2024.04.010_bib7","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1161\/CIRCULATIONAHA.118.034646","article-title":"A\u00a0simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib8","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1161\/CIRCULATIONAHA.117.030093","article-title":"High prevalence of occult heart failure with preserved ejection fraction among patients with atrial fibrillation and dyspnea","volume":"137","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib9","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1093\/eurheartj\/ehy268","article-title":"Haemodynamics, dyspnoea, and pulmonary reserve in heart failure with preserved ejection fraction","volume":"39","author":"Obokata","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.04.010_bib10","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/jamacardio.2022.1916","article-title":"Diagnosis of heart failure with preserved ejection fraction among patients with unexplained dyspnea","volume":"7","author":"Reddy","year":"2022","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jchf.2024.04.010_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ejhf.2122","article-title":"A\u00a0Prospective Study Using Invasive Haemodynamic Measurements Following Catheter Ablation for AF and Early HFpEF: STALL AF-HFpEF","volume":"23","author":"Sugumar","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.010_bib12","first-page":"646","article-title":"Atrial fibrillation ablation for heart failure with preserved ejection fraction: a randomized controlled trial","volume":"11","author":"Chieng","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2024.04.010_bib13","first-page":"461","article-title":"Resting and exercise-induced left atrial hypertension in patients with atrial fibrillation: the causes and implications for catheter ablation","volume":"3","author":"Sramko","year":"2017","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jchf.2024.04.010_bib14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cardfail.2017.04.002","article-title":"Prevalence and predictors of early heart failure with preserved ejection fraction in patients with paroxysmal atrial fibrillation","volume":"23","author":"Meluzin","year":"2017","journal-title":"J\u00a0Card Fail"},{"issue":"11","key":"10.1016\/j.jchf.2024.04.010_bib15","first-page":"1626","article-title":"Identification of subclinical heart failure with preserved ejection fraction in patients with symptomatic atrial fibrillation","volume":"11","author":"Ariyaratnam","year":"2023","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2024.04.010_bib16","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1002\/ejhf.3020","article-title":"Provocative testing in the evaluation of heart failure with preserved ejection fraction: not all stresses are created equal","volume":"25","author":"Reddy","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.010_bib17","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1093\/eurheartj\/ehad592","article-title":"Prevalence and incidence of diastolic dysfunction in atrial fibrillation: clinical implications","volume":"44","author":"Naser","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.04.010_bib18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.04.010_bib19","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.04.010_bib20","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1161\/CIRCULATIONAHA.123.065134","article-title":"Cardiac and Metabolic Effects of Dapagliflozin in Heart\u00a0Failure With Preserved Ejection Fraction: the CAMEO-DAPA trial","volume":"148","author":"Borlaug","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib21","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N\u00a0Engl J Med"},{"issue":"15","key":"10.1016\/j.jchf.2024.04.010_bib22","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1161\/CIRCULATIONAHA.119.044183","article-title":"Effect of dapagliflozin on atrial fibrillation in patients with type 2 diabetes mellitus: insights from the DECLARE-TIMI 58 trial","volume":"141","author":"Zelniker","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib23","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1002\/ejhf.2861","article-title":"Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation","volume":"25","author":"Filippatos","year":"2023","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.010_bib24","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41591-023-02526-x","article-title":"Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial","volume":"29","author":"Borlaug","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.jchf.2024.04.010_bib25","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1001\/jama.2013.280521","article-title":"Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial","volume":"310","author":"Abed","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jchf.2024.04.010_bib26","first-page":"455","article-title":"An Exercise and Physical Activity Program in Patients With Atrial Fibrillation: the ACTIVE-AF randomized controlled trial","volume":"9","author":"Elliott","year":"2023","journal-title":"J\u00a0Am Coll Cardiol EP"},{"key":"10.1016\/j.jchf.2024.04.010_bib27","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/ejhf.812","article-title":"High prevalence of subclinical cerebral infarction in patients with heart failure with preserved ejection fraction","volume":"19","author":"Cogswell","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.010_bib28","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1093\/eurheartj\/ehad338","article-title":"Stroke in patients with heart failure and reduced or preserved ejection fraction","volume":"44","author":"Yang","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.04.010_bib29","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1002\/ejhf.2142","article-title":"Diagnostic scores predict morbidity and mortality in patients hospitalized for heart failure with preserved ejection fraction","volume":"23","author":"Verbrugge","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.010_bib30","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008176","article-title":"Detection of left atrial myopathy using artificial intelligence-enabled electrocardiography","volume":"15","author":"Verbrugge","year":"2022","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2024.04.010_bib31","first-page":"742","article-title":"Risk of stroke in chronic heart failure patients with preserved ejection fraction, but without atrial fibrillation: analysis of the CHARM-Preserved and I-Preserve trials","volume":"38","author":"Abdul-Rahim","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2024.04.010_bib32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1056\/NEJMoa2310234","article-title":"Apixaban for Stroke Prevention in Subclinical Atrial Fibrillation","volume":"390","author":"Healey","year":"2024","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jchf.2024.04.010_bib33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1056\/NEJMoa2303062","article-title":"Anticoagulation with edoxaban in patients with atrial high-rate episodes","volume":"389","author":"Kirchhof","year":"2023","journal-title":"N\u00a0Engl J Med"},{"issue":"10310","key":"10.1016\/j.jchf.2024.04.010_bib34","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(21)01637-8","article-title":"Clinical Outcomes in Systematic Screening for Atrial Fibrillation (STROKESTOP): a multicentre, parallel group, unmasked, randomised controlled trial","volume":"398","author":"Svennberg","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.jchf.2024.04.010_bib35","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S0140-6736(21)01698-6","article-title":"Implantable loop recorder detection of atrial fibrillation to prevent stroke (the LOOP study): a randomised controlled trial","volume":"398","author":"Svendsen","year":"2021","journal-title":"Lancet"},{"issue":"13","key":"10.1016\/j.jchf.2024.04.010_bib36","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/CIRCULATIONAHA.123.067512","article-title":"Direct oral anticoagulants for stroke prevention in patients with device-detected atrial fibrillation: a study-level meta-analysis of the NOAH-AFNET 6 and ARTESiA trials","volume":"149","author":"McIntyre","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.120.050991","article-title":"Ablation versus drug therapy for atrial fibrillation in heart failure: results from the CABANA trial","volume":"143","author":"Packer","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib38","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1161\/CIRCULATIONAHA.121.056323","article-title":"Early rhythm control therapy in patients with atrial fibrillation and heart failure","volume":"144","author":"Rillig","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2024.04.010_bib39","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.hrthm.2020.12.025","article-title":"The role of timing in treatment of atrial fibrillation: an AFFIRM substudy","volume":"18","author":"Yang","year":"2021","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.jchf.2024.04.010_bib40","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1016\/j.jacc.2018.03.519","article-title":"Progression of device-detected subclinical atrial fibrillation and the risk of heart failure","volume":"71","author":"Wong","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924003299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213177924003299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T02:31:14Z","timestamp":1748745074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213177924003299"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2213177924003299"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2024.04.010","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening for Unrecognized HFpEF in Atrial Fibrillation and for Unrecognized Atrial Fibrillation in HFpEF","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2024.04.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}